Motley Rice

- Motley Rice attorney Jonathan Orent, co-lead counsel and a member of the Plaintiffs' Executive Committee (PEC) for MDL against Novo Nordisk and Eli Lilly, makers of diabetes and weight loss drugs including Ozempic®, Wegovy®, Mounjaro® and other GLP-1 RA medications.

"Drugmakers like Novo Nordisk and Eli Lilly must be held accountable for downplaying dangers in ads that are arguably deceptive and misleading. We no longer have to wait for a legal reckoning for drugmakers that aren’t fully transparent — it’s here.”

“The FDA’s action underscores what our clients know all too well — aggressive marketing without full disclosure puts patients at serious risk."

Meta covered up potential child harms, whistleblowers claim Meta denies the allegations and described the "claims at the heart" of the Senate hearing as "nonsense".

At Motley Rice, we remain committed to seeking justice and holding Big Tech companies, like Meta, accountable for alleged harmful conduct.

Learn more:

During the US Senate committee hearing on September 9, 2025, two former Meta safety researchers alleged that Meta covered up potential harms to children stemming from its reality (VR) products.

We applaud the witnesses for their brave testimonies.

“This ruling out of the federal court in Manhattan marks a significant achievement for the families of victims”, says Motley Rice attorney Don Migliori.

Learn more via @usatoday.com

After decades of litigation, a federal judge has ruled that claims brought by the 9/11 families and victims against the Kingdom of Saudi Arabia may proceed.

Sudden blindness possible rare side effect of popular diabetes & weight loss drugs A growing number of patients claim popular weight loss and diabetes drugs like Ozempic can cause a rare but very serious side effect they were never warned abou

Our client, Todd Engel shares his story in hopes of raising awareness of the potential risk for sudden blindness when using semaglutides:

Vision loss is not a side effect; it’s a life-altering complication.

As new research emerges on the risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) for patients using GLP-1 drugs, the manufactures have both the duty and the power to act.

Judge allows families of 9/11 victims to sue Saudi Arabia for allegedly helping hijackers A federal judge in New York kept alive a lawsuit accusing officials in Saudi Arabia of assisting the Sept. 11 hijackers — which the Saudi government has vehemently denied.

[...] and noted that a public trial will determine the rest." - MDL co-lead and Motley Rice attorneys Jodi Westbrook Flowers and Donald Migliori

"The court concluded “the total evidence creates a high probability as to Bayoumi and Thumairy’s roles in the hijacker’s plans, and the related role of their employer [Saudi Arabia]” [...]

“Today’s landmark decision in the September 11, 2001 case marks an important day for justice. [...]

Jonathan appeared on Spotlight America to discuss the growing concerns over potentially serious side effects of specific weight loss prescription medicines: ktvl.com/news/spotlig...

“We're seeing many patients who have been severely harmed by these drugs, and, in fact, we've seen more than a few who have actually died as a result of their injuries." - Motley Rice attorney and co-lead counsel for the GLP-1 MDL, Jonathan Orent.

Over 10,000 Women Now Allege That Toxic Chemicals in Hair Relaxers Gave Them Cancer - Consumer Reports Three women tell their stories about their experiences using relaxers, and what their diagnoses have meant for their and their families' lives.

We are proud of our clients for bravely sharing their stories to help raise awareness of health risks they claim are from chemical hair relaxers.

Learn more about these victims and the ongoing litigation:

“[The manufacturers] should be ashamed of themselves. They should know how hard it is for people, and how we are out here suffering. Even years later, I’m still suffering.” – Ariane Clayton, one of Motley Rice’s many clients in the MDL hair relaxer litigation.

'A Daft Suggestion': Judge Declines to Kick Hundreds of Paraquat Cases Out of Philadelphia | Law.com Judge Joshua Roberts of the Philadelphia Court of Common Pleas on July 11 denied a motion from Syngenta Crop Protection LLC and Chevron U.S.A. Inc. that challenged the plaintiffs’ choice of forum in P...

Learn more about the latest developments:

CASE UPDATE: The first paraquat trial in the U.S. is set to go before a jury this October. Motley Rice attorney and Plaintiffs' Liaison Counsel Mike Daly shares insights on this milestone in the Paraquat litigation.

Boeing 787 software may have caused AI crash: Aviation expert  - The Sunday Guardian Live Mary Schiavo warns Air India crash may involve Boeing 787’s software-triggered engine thrust rollback malfunction. NEW DELHI: In a wide-ranging exclusive

Watch the full interview here:

"The investigators need to carefully review the aircraft maintenance and repair records, thoroughly examine what the NTSB 787 investigation revealed, investigate what data and records they had from Boeing, and equally important, explore what they didn't previously receive or review from Boeing.”

Does Boeing have a software issue in their airplanes? Motley Rice aviation attorney and former Inspector General of the United States Department of Transportation Mary Schiavo discussed the Air India Flight AI-171 crash with The Sunday Guardian.

YouTube video by CNN Aviation experts react to video showing plane just before crash

Motley Rice aviation attorney and @cnn.com analyst Mary Schiavo explains what the video of the Boeing 787 jet crash, Flight AI171, in India tells us about the tragedy:

Berkeley County Receives Funding from National Opioid Settlement | The Berkeley Observer Berkeley County has received an installment of $707,968.64 as part of a $26 billion national opioid settlement.

The application period for organizations seeking funds runs from June 9 to June 25, 2025.

Learn more:

“While these settlement funds cannot turn back the clock on the national opioid crisis, they help many of our local communities continue to move forward from the damage these drugs have done.” - Motley Rice co-founder and National Prescription Opiate MDL co-lead counsel Joe Rice.

Berkeley County has received funds as part of a $26 billion national opioid settlement, which the County plans to distribute to local organizations and agencies helping fight the opioid epidemic.

Over 10,000 Women Now Allege That Toxic Chemicals in Hair Relaxers Gave Them Cancer - Consumer Reports Three women tell their stories about their experiences using relaxers, and what their diagnoses have meant for their and their families' lives.

As part of the Consumer Reports’ Beauty Justice series, our brave clients share their experiences with the use of chemical hair straightening in their youth and the challenge of being diagnosed with cancer.

These are their stories:

The article highlights Joe’s decades-long career, which has been marked by groundbreaking settlements and driven by his ability to bring people together to negotiate complex, high-stakes cases.

Here’s the full article: lnkd.in/gx_XAYed

Read more from “The Master of Negotiation” Joe Rice, who is featured on the cover of South Carolina Super Lawyers magazine.

Ozempic’s double-sided coin: Amid skyrocketing popularity of GLP-1 drugs, a burgeoning lawsuit looms Patients have found the medications to be life-changing in ways both positive and negative.

“We believe that the labels put forward by the defendants were insufficient for doctors and regular people to understand the risk.” – Motley Rice attorney Jonathan Orent.

Learn more:

A hearing is set for Wednesday to present arguments regarding the plaintiffs’ diagnosis of gastroparesis allegedly from using GLP-1 drugs like Ozempic®.